“The team at Scius have been an invaluable support during such a pivotal year for us. They have deep expertise in supporting companies through financing announcements and effectively co-ordinated with our key stakeholders. We were delighted by the coverage achieved in the major trade publications.”

 Nicola Thompson, CEO of Amphista Therapeutics

Objectives

  • Promote Amphista as a pioneer and global leader in the TPD space
  • Highlight the experience of the world class leadership team
  • Raise awareness of the rapid progress from a $7.5m Series A to a $53m Series B in under a year, including a broad range of leading life-science and corporate investors in an oversubscribed round.

Strategy

  • Liaising with the key stakeholders, including several investors, involved in the Series B to co-ordinate timings, sign-off and quotes for the announcement
  • Drafting announcement, key messages and QA and co-ordinating with stakeholders
  • Pre-briefing target journalists under embargo and setting up one-on-one briefings in advance of the news, with further media follow up on day of release

Results

  • Extensive global trade media coverage (BioCentury, BioWorld, and Endpoints), as well as local press in Scotland including The Herald, The Times, Daily Business, and The Scotsman.